Stay updated on Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial page.

Latest updates to the Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 was added and revision: v3.4.1 was removed.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision: v3.4.1 was added; the funding-lapse notice and Revision: v3.4.0 were removed.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded glossary display, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.3.4 was added and the previous revision v3.3.3 was removed. This update concerns internal version labeling and does not change content or user-facing behavior.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a Locations section listing participating sites by state/province and country (e.g., Alabama, Arizona, California, Ontario, Alberta). The revision tag was updated to v3.3.3.SummaryDifference1%

- Check87 days agoChange DetectedLocation updates: Harrison, NY 10604 removed and East White Plains, NY 10604 added. The duration of maintenance chemotherapy outcome description was updated to say 'from randomization to last chemotherapy, which continues until progression or significant toxicity' with a maximum follow-up of 5.4 years, replacing the prior 'Duration of Maintenance Chemotherapy Usage' (up to 3 years).SummaryDifference0.1%

Stay in the know with updates to Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial page.